華銘智能(300462.SZ):子公司智達信首次被認定為高新技術企業
格隆匯 3 月 4日丨華銘智能(300462.SZ)公佈,公司全資子公司智達信自動化設備有限公司(“智達信”)於近日收到浙江省科學技術廳、浙江省財政廳、國家税務總局浙江省税務局聯合頒發的《高新技術企業證書》,智達信首次被國家高新技術企業認定管理機構評定為高新技術企業。
智達信首次被認定為高新技術企業,根據國家對高新技術企業税收優惠政策的有關規定,智達信自通過高新技術企業認定起連續三年內(2020年度—2022年度),可享受國家關於高新技術企業的税收優惠政策,即按15%的税率繳納企業所得税。上述税收優惠政策對公司2020年度的經營業績不會產生重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.